Related Experiment Videos

Mouse models in tumor suppression

N Ghebranious1, L A Donehower

  • 1Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA.

Oncogene
|January 23, 1999
PubMed

Insights

Tumor suppressor gene mutations drive cancer. Genetically engineered mice with these mutations offer powerful models to study cancer development and progression in vivo and in vitro.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Tumor suppressor genes regulate cell growth and are frequently mutated in cancers.
  • Understanding their function has relied on cell culture studies.
  • Gene targeting in embryonic stem cells enables the creation of mice with germline mutations in these genes.

Purpose of the Study:

  • To review mechanistic insights gained from studying tumor suppressor-deficient mice.
  • To highlight the utility of these mice as models for human cancer syndromes.

Main Methods:

  • Generation of mice with germline tumor suppressor gene mutations via gene targeting in embryonic stem cells.
  • In vivo studies of tumor initiation and progression in these 'knockout' mice.
  • In vitro studies using primary cells derived from tumor suppressor-deficient mice.

Main Results:

  • Insights into the roles of tumor suppressors in development, differentiation, cell cycle control, and tumor suppression.
  • Demonstration of utility as disease models for inherited cancer predisposition syndromes.
  • Facilitation of in vivo and in vitro studies on gene loss in cancer initiation, progression, and cellular processes like DNA damage response and apoptosis.

Conclusions:

  • Tumor suppressor-deficient mice provide crucial insights into cancer mechanisms.
  • These mouse models are invaluable for studying cancer biology and developing therapeutic strategies for human cancer syndromes.

Related Concept Videos